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Reports of rapid accumulation of 3H- or 14C-labelled hexamethonium in cartila- 
ginous tissues after intravenous administration to rats and mice and of binding of 
hexamethonium to chondroitin sulfate in uitro prompted synthesis of radioiodinated 
analogs of hexamethonium. Tissue distribution studies in rats performed at 0.5 and 
2 h after intravenous administration of “C-hexamethonium confirmed the propensity 
of this drug to accumulate in cartilaginous tissues. Tissue distribution studies were 
performed in both normal and chondrosarcoma tumor-bearing rats at 0.5 and 2 h 
after intravenous administration of the radioiodinated analogs. The radioiodinated 
analogs showed profiles of distribution of radioactivity comparable to that of hexa- 
methonium. Levels of uptake were highest in kidney and urine at all time periods 
studied. High levels of activity were seen in trachea, intervertebral discs and, when 
present, tumor. A rapid dispersal of a relatively low level of radioactivity was seen 
in most other tissues and was followed by rapid clearance in all tissues except men- 
inges which continued to accumulate radioactivity for as long as 2 h. A chondrosar- 
coma tumor was successfully imaged in a rat 15 min following intravenous adminis- 
tration of a radioiodinated analog of hexamethonium. 
Introduction 
GLYCOSAMINOGLYCANS (mucopolysaccharides) are an ill-defined group of compounds 
which form the amorphous ground substances of connective tissue, the blood group 
specificity substances, and the protective mucous secretions of the digestive and respira- 
tory passages. They are nearly always associated with proteins in some way. A character- 
istic feature of these macromolecules is the presence of many closely packed, negatively 
charged groups associated with repeating disaccharide units. As a result of this anionic 
nature. they show a great affinity for quaternary and especially bisquaternary drugs. 
These macromolecules represent sites of loss for the quaternary drugs as interaction 
results in no physiological effect. 
Hexamethonium is a bisquaternary, anti-hypertensive agent which acts at the gang- 
lionic synapse by antagonizing acetylcholine. (l) This agent has been shown to accumulate 
in poorly vascularized tissues such as cartilage within minutes after administration. Auto- 
radiographic studies in mice and rats have shown selective concentration of 3H- or 
14C-hexamethonium in articular cartilage and intervertebral disc as compared to sur- 
rounding tissues. ~3~) The high levels of radioactivity in cartilaginous tissues of mice 
following administration of 3H-hexamethonium has been shown to be associated with 
areas presumably containing glycosaminoglycans.‘3’ Quaternary ammonium compounds 
have also been shown to bind in vitro to glycosaminoglycans such as chondroitin sul- 
fate.‘2,4’ 
Agents such as these when appropriately radiolabelled could be useful tools in diag- 
nosis of diseases of cartilage and of diseases characterized by localized increases in 
levels of glycosaminoglycans such as regions of inflammation, arthritis and cystic fibrosis. 
Hexamethonium has been radiolabelled with ’ 'C and preliminary evaluations have been 
encouraging. (V However, the short half-life of “C (20 min) may limit its availability 
for clinical use. 
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Thus, a goal in our laboratory has been the structural modification of the hexameth- 
onium molecule to allow incorporation of a foreign y-emitting nuclide (radioiodine) 
without the loss of characteristics which are essential for accumulation in cartilage. 
Substitution of the C6 polymethylene chain of hexamethonium with a xylylene group 
was an attractive modification as it allowed introduction of an aromatic radiohalogen 
which would be more stable than an aliphatic halogen. Moreover, the p-xylylene substi- 
tuted hexamethonium analog has been shown to have no significant ganglionic blocking 
activity in the cat. W) It was hoped that the lower ganglionic blocking activity of these 
analogs would not decrease their ability to bind at anionic sites of loss present in 
cartilaginous tissues. 
Thus, two radioiodinated analogs of hexamethonium have been synthesized and evalu- 
ated in normal and tumored rats for their ability to concentrate in tissues known to 
contain high concentrations of glycosaminoglycans. 
Materials and Methods 
Radiolabelled compounds 
The synthesis of 14C-hexamethonium (Fig. 1, Scheme I) was accomplished by treat- 
ment of N,N,N’,N’-tetramethyl-1,6-hexanediamine with i4CH.,I. An excess of the tertiary 
amine was used to ensure complete utilization of i4CH31. Subsequent addition of un- 
labelled CHJ assured complete quaternization. Purity of the product was confirmed 
by thin-layer chromatography (TLC) using silica gel plates developed in CHCl, : MeOH 
(1:2). 
Iodinated analogs of hexamethonium (NM-194 and NM-202) were synthesized using 
the general method (Scheme II) in Fig. 1. Results of NMR (Varian A-60A), i.r. (Perkin- 
Elmer 281) and elemental analyses (Spang Microanalytical Laboratory, Ann Arbor, 
Michigan, or Midwest Microlab, Inc., Indianapolis, Indiana) on the final product and 
on all intermediates were all consistent with the proposed structures. Melting points 
(Thomas-Hoover Apparatus, uncorrected) of the two analogs were para-243°C dec, and 
meta-250°C dec. TLC analyses of the compounds were performed using either silica 
gel or cellulose plates (Eastman Kodak) developed in methyl cellosolve:propionic acid: 
water (15: 15: 70) saturated with NaCl. Iodine vapor or U.V. light were used to visualize 
the spots. R, values for the para analog were 0.30 and 0.93 for silica gel and cellulose, 
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FIG. 1. Synthetic route for ‘T-hexamethonium (Scheme I) and radioiodinated hexameth- 
onium analogs (Scheme II). 
Bisquaternary ammonium compounds 15s 
Incorporation of radioiodide into the analogs was achieved by exchange reaction 
with Na1251 performed on the tertiary amines followed by qtiaternization with CH,I. 
Radiochemical purity was confirmed by TLC analysis using the systems described above. 
A sample of each radiolabelled analog and the corresponding authentic non-radio- 
labelled compound were co-chromatographed. The location of the radioactive peak 
(determined by a Baird Atomic Radiochromatogram Scanner) was coincident with the 
location of the spot from the unlabelled material. No other radioactive peaks or spots 
were detectable. 
The “C-hexamethonium (15 mg, 310 &i) was dissolved in saline (5 ml) for use in 
tissue distribution studies. The meta analog (12.5 mg, 1.3 mCi) was dissolved in saline 
(5 ml). The para analog was synthesized twice for tissue distribution studies. For the 
studies in normal animals, 26 mg of compound (250 $i) was dissolved in saline (2 ml). 
For the studies in tumored rats, 8 mg of compound (280 @i) was dissolved in saline 
(2 ml). The compound dose for tissue distribution studies was 0.8-1.4 mg/kg except for 
studies in normal rats using the para analog when 5.c6.0 mg/kg was given. A third 
synthesis of the para analog, necessary for the scan attempt, resulted in 34 mg of com- 
pound (1.7 mCi) which was dissolved in saline (1 ml). 
Tissue distribution studies in normal ruts 
Adult male Sprague-Dawley rats (Spartan Research Animals, Haslett, Michigan) 
weighing 2OG300 g were used as experimental animals. The rats were housed in tempera- 
ture and light-controlled quarters and had access to food (Teklad 4% Rat and Mouse 
Diet) and water ad libitum. The rats received intravenous injections of the test materials 
via the tail vein in 0.1 ml of saline, while under ether anesthesia. The rats were killed 
by cardiac exsanguination under ether anesthesia. 
Each of 15 rats received 6.3 PCi of “C-hexamethonium and was killed at either 0.5 h 
(2 groups of 5 rats) or 2 h (5 rats) post-injection. Twenty rats were divided into 2 
groups and the rats each received either 11.7-12.3 PCi of the puru analog (10 rats) 
or 23.8-25.1 &i of the mefa analog (10 rats). Half of the rats in each group were 
killed at 0.5 h and half were killed at 2 h post-injection. Following the killing of all 
rats, samples of blood were taken and the major organs removed, dissected free of 
fat and connective tissue, blotted dry and weighed. Large organs were minced with 
scissors. Samples of tissues from rats that received 14C-hexamethonium were placed 
in tared liquid scintillation vials and weighed. To each vial was added 0.3 ml of 2 N 
NaOH solution and the vials were allowed to digest overnight. The vials were heated 
on a hot plate at 40°C for 5-10 min to complete digestion and then allowed to cool 
whereupon 50 ~1 of Hz02 (30% solution) was added to each vial. The vials were reheated 
at 40°C for l-3 min and allowed to cool. Enough 0.5 M acetic acid to neutralize the base 
and 13.5 ml of PCS (Amersham Corp.) were added and the vials shaken on a vortex 
mixer. The samples were assayed for radioactivity in a liquid scintillation counter (Beck- 
man LS-150) for 10 min or until enough counts had accumulated to reduce counting 
error to 27; at 95% confidence level, whichever was shorter. For samples which counted 
the full 10 min, maximum counting error at 95% confidence level was 10%. The observed 
cpm were corrected for efficiency using the external standard channels ratio method. 
Samples from rats that received radioiodinated analogs were placed in tared cellulose 
acetate capsules and weighed. The capsules were then placed in counting tubes and 
assayed for radioactivity in a well scintillation counter (Searle Automatic Gamma Sys- 
tem) for 10 min or until enough counts had accumulated to reduce counting error 
to 2?, at 95% confidence level, whichever was shorter. For samples which counted 
the full 10 min, maximum counting error at 95% confidence level was 6%. Counting 
efficiency for 125I was 87%. 
Chondrosarcomu tumor model 
Two rats inoculated 10 weeks previously with the Swarm transplantable chondrosar- 
coma tumor first described by CHOI et ~1.‘~) and characterized by OEGEMA et a1.@) 
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were received from the laboratory of Dr Dominic Dziewiatkowski of The University 
of Michigan, Ann Arbor. These rats were used to start the tumor line carried in this 
laboratory, and the transplantation procedure routinely used was as follows: donor 
rats were killed with ether, and the tumors removed and placed on ice. Samples of 
these tumors were preserved in 10°I,; formalin solution for histopathological evaluation. 
The remaining portions of the tumors were finely minced with scissors, and 0.1 ml 
of the tumor mince was injected via syringe subcutaneously into the left flank of male 
Sprague-Dawley rats weighing 180-200g. At 68 weeks following tumor inoculation 
these rats had tumors of adequate size for experimental use. Rats weighed 35&45Og 
at this time. 
Tissue distribution studies in tumor-hewing ruts 
Twenty tumor-bearing rats were divided into two groups and the rats each received 
either 22.8-23.1 &i of the para analog (10 rats) or 24.7-25.OpCi of the meta analog 
(10 rats). Half of the rats in each group were killed at 0.5 h and half of the rats were 
killed at 2 h post-injection. Tissue handling was as described for tissues from normal 
rats receiving radioidinated compounds. In addition, samples of each tumor were pre- 
served in 10% formalin solution for histopathological evaluation. Urine samples obtained 
from some of these rats were also analyzed using the TLC system described for the 
radioiodinated hexamethonium analogs. An aliquot of the solution injected was chroma- 
tographed concurrently with the urine samples for comparison. The TLC plates were 
scanned to locate the radioactivity on the plates (Berthold Radio Scanner Model 6000). 
Scan of chondrosarcoma-tumored rat 
Five tumored rats received intravenous injections of the paru analog at doses ranging 
from 83-178 &i (1.7-6.5 mg). Higher radioactive doses were required for detection of 
activity with the small animal scanner. Animals were killed by ether overdose at 
5-30 min post-injection and scanned using a small animal scanner (Berthold Radio Scan- 
ner Model 6000). Following completion of one scan, the tumors were removed and 
the animals rescanned. After the second scan was complete, samples of tumor and other 
tissues were assayed for radioactivity as described previously. 
Results of tissue distribution studies are expressed as ‘<, administered dose/gram of 
tissue and were calculated as follows: 
Sample dpm x 100 mg/g % dose/g = ~_._~_______~ ._~~ .~ - xl00 
sample wt (mg) x 22.2 x lo- dpm/lcCi x dose (IKi) 
Results 
The distribution of radioactivity following intravenous injection of 14C-hexameth- 
onium or its radioiodinated analogs to normal and/or tumored rats is summarized 
in Table 1. 
The distribution of radioactivity following injection of “C-hexamethonium to normal 
rats is comparable to that reported for autoradiographic studies in rats and mice by 
WASSERMAN(~) and ASGHAR and ROTH.“) The highest concentration of radioactivity was 
seen in the kidney at all time periods studied. There was a rapid dispersal of a relatively 
low level of activity in most tissues followed by a rapid clearance. The clearance of 
radioactivity from the blood was especially rapid with “d dose/g values of 0.310 f 0.028 
and 0.020 _+ 0.006 at 0.5 and 2 h, respectively. High levels of uptake were seen in trachea 
and intervertebral discs initially which were also cleared rapidly, although not as rapidly 
as blood. Trachea-to-blood ratios were 3.7 f 0.8 and 6.9 + 1.0 at 0.5 and 2 h, respect- 
ively. The tendons and articular cartilage showed higher levels of uptake than surround- 
ing muscle. While there was very little concentration of radioactivity in the brain, the 
meninges showed initially moderate levels of uptake at 0.5 h which increased at 2 h. 
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TABLE 2. Radioactivity in tissues of rats scanned after injection of the radioiodinated para analog of 
hexamethonium 
s/, Dose/g 
Time (min) Dose (&i) Scan results Kidney Liver Tumor 
5 104 - 2.538 0.323 0.175 
15 83 - 2.700 0.598 
15 I78 + 2.020 0.144 0.647 
25 83 _ 3.958 0.477 
30 83 - 3.084 0.142 0.48 1 
Meninges-to-brain ratios were 17.7 + 1.8 and 25.3 + 7.3 at 0.5 and 2 h, respectively. 
Intravenous administration of either radioiodinated analog of hexamethonium also 
resulted in highest levels of radioactivity being present in the kidneys at both time 
periods studied. There was also a rapid dispersal of relatively low levels of radioactivity 
throughout the tissues followed by rapid clearance. Trachea and intervertebral discs 
had high levels of activity, although not as high as when 14C-hexamethonium was 
administered. Trachea-to-blood ratios were 3.0 1 0.4 and 6.2 + 0.9 for the para analog 
and 4.0 k 0.5 and 6.2 + 0.6 for the meta analog at 0.5 and 2 h, respectively, and similar 
ratios were noted for intervertebral discs. As with “C-hexamethonium, the levels of 
radioactivity increased with time in meninges. The meninges-to-brain ratios were 
11.5 + 1.9 and 17.4 + 3.1 for the para analog and 10.8 & 0.6 and 15.1 + 2.0 for the 
meta analog at 0.5 and 2 h, respectively. 
Tumors developed in all rats injected with tumor mince. Histopathological evaluation 
of the tumors* confirmed that these tumors were chondrosarcomas. Measurements taken 
of the tumors at their greatest lengths in two perpendicular directions varied from 
1.0 x 2.0 to 2.7 x 4.0 cm and weights varied from 1.04 to 7.66 g. 
Distribution of radioactivity following intravenous administration of radioiodinated 
hexamethonium analogs to chondrosarcoma tumor-bearing rats was not significantly 
different from results in normal rats. Levels of uptake in the tumors were similar to 
that in the trachea. Tumor-to-blood ratios were 3.0 + 0.3 and 6.3 + 1.1 for the para 
analog and 3.9 + 0.4 and 7.1 + 0.5 for the meta analog at 0.5 and 2 h, respectively. 
Urine obtained from the bladder of 17 of the 20 tumored rats had levels of radioactivity 
ranging from l&93% dose/g at 0.5 h and 646% dose/g at 2 h post-injection. As no 
attempt was made to collect all urine excreted between injection and killing, calculations 
of total amounts of radioactivity present in the urine cannot be made. If enough urine 
remained after counting samples had been taken, TLC analyses were performed. TLC 
analysis of urine from five of the rats (para analog-3, meta analog-2) killed at 0.5 h 
post-injection showed only one detectable radioactive peak which had the same R, 
value as the injected material which was cochromatographed with the urine samples. 
In some, but not all, 2 h urine samples, a shoulder was apparent in the radioactive 
peak which may be indicative of another metabolite. Further characterization of urinary 
radioactivity was not attempted. 
Initial attempts to visualize the chondrosarcoma tumor were unsuccessful. The 
radioiodinated pava analog was used for imaging studies with the small animal scanner. 
A dose of 83 &i (4.2-5.0 mg/kg) was given to each of the 3 rats which were killed 
at 15, 25 or 30 min after injection. Although results of these scans were encouraging, 
close proximity of the tumor to the kidneys prevented positive indentification. A fourth 
rat was injected with 104 &i (8.2 mg/kg) and killed 5 min post-injection. The tumor 
was not visualized. Subsequent analysis of the tissues showed that levels of activity 
in the tumor at 5 min were only 0.175’% dose/g. A final attempt to visualize the tumor 
* Performed by Drs D. A. Repola and R. H. Nishiyama of the Department of Pathology at 
The University of Michigan. 
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FIG. 2. Scan of chondrosarcoma tumored rat using the para analog at 15 min after i.v. 
injection. Urine from the bladder was withdrawn with a syringe. 
was made after preparation of a fifth rat with the tumor mince injected subcutaneously 
over the left rear leg instead of the left flank. A 15-min interval was selected because 
this time period gave the highest radioactivity in the tumors of the other 4 rats studied 
(Table 2). The dose injected was 178 &i (15.8 mg/kg). Foilowing injection, the rat exhi- 
bited tremors and decreased motor activity. No visible signs of intoxication were seen 
with the other rats in this study. The initial scan of the fifth tumored rat showed 
four areas of increased radioactivity. Two of these corresponded to the position of 
the kidneys and the third was thought to represent urinary activity in the bladder. 
The fourth area corresponded to the location of the tumor. A syringe was used to 
remove the urine from the bladder, and the animal was rescanned. Only three areas 
of increased radioactivity remained (Fig. 2). When the animal was rescanned following 
removal of the tumor, the corresponding area of increased radioactivity was no longer 
evident (Fig. 3). 
Kidneys 
FIG. 3. Rescan of rat in Fig. 2 following removal of the chondrosarcoma tumor. 
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Discussion 
As reported in the literature,‘2’ and confirmed in this study, hexamethonium accumu- 
lates rapidly in avascular tissues such as cartilage following injection to rats. Radioac- 
tivity in such tissues after administration of radiolabelled hexamethonium is related 
to the tissue concentration of negatively-charged glycosaminoglycans,(3) and such tissues 
represent sites of loss for bisquaternary drugs. The structural alterations present in 
the analogs of hexamethonium evaluated in this study allow for retention of the ability 
to accumulate in cartilaginous tissues as well as introduction of a y-emitting nuclide. 
The rapid urinary excretion reported for hexamethonium’9~‘0’ is apparently respon- 
sible for the high levels of radioactivity in the kidneys after injection of the 14C-labelled 
compound. High renal activity was also seen following administration of either radioio- 
dinated analog suggesting that the kidneys are important in clearance of these com- 
pounds. 
Hexamethonium is not metabolized in viuo and has been isolated unchanged from 
the urine in several species. (il) TLC analysis of urine from rats 0.5 h after administration 
of the radioiodinated hexamethonium analogs showed only one radiolabelled product 
with Rf value the same as the injected material suggesting no detectable in vivo metabo- 
lism. By 2 h after administration, however, a second radioactive substance seen as a 
shoulder on the radioactive peak was detectable in some urine samples. Further work 
is necessary to ascertain the exact structures of the radioactive product(s) present in 
the urine. The low levels of radioactivity present in the thyroid indicate a minimum 
amount of in viuo deiodination. 
The meninges showed a delayed pattern of accumulation of radioactivity as compared 
to other cartilaginous tissues. While these tissues showed highest levels of radioactivity 
at 0.5 h, it was at the 2-h interval when radioactivity in other tissues had decreased 
that meninges showed highest uptake. This delayed uptake resulted in favorable men- 
inges-to-blood and brain ratios suggesting that agents of this type may also have value 
in the diagnosis of meningiomas. 
Visible toxic effects were only seen when high dose (15 mg/kg) of low specific activity 
material were administered for imaging purposes. Doses as high as 8 mg/kg resulted 
in no apparent toxic effects. Nonetheless, future studies should strive for the use of 
agents with a specific activity in the order of at least 1 mCi/mg to minimize possible 
pharmacological effects. 
The feasibility of using these hexamethonium analogs for imaging areas of glycos- 
aminoglycan concentration has been shown by successful visualization of a rat chondro- 
sarcoma tumor. The clinical use of these hexamethonium analogs as scanning agents 
would require the substitution of lz51 with the more energetic isotopes of iodine such 
as i3iI and 1231. The short time required for synthesis of these analogs as well as 
the ability of the compounds to accumulate in target tissues at early time periods makes 
labelling with 123I feasible. 
The encouraging results obtained in these preliminary studies with two radioiodinated 
hexamethonium analogs suggest that further studies be carried out in larger animals 
to confirm accumulation of these compounds in cartilage of other species and to evaluate 
their toxicity at doses necessary for scanning. 
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